TL;DR
This study reveals that OXA-244, a carbapenemase-producing Escherichia coli variant, has become the dominant OXA-48-like subtype in a major Jerusalem hospital, challenging previous assumptions about its prevalence in Israel. The research highlights a complex interplay of healthcare-associated and community transmission, driven by the unique chromosomal integration of the bla<sub>OXA-244</sub> gene within the Tn51098 transposon, suggesting a need for enhanced, community-focused surveillance.
What Problem Does This Paper Address?
Carbapenemase-producing Enterobacterales (CPE) are a critical global health threat due to their resistance to last-resort antibiotics. Among CPEs, OXA-48-like carbapenemases have emerged as a significant concern, with various subtypes exhibiting different geographical distributions. While OXA-48-like carbapenemases were first identified in Israel in 2007, the specific subtype OXA-244, known for its rapid spread and challenging detection due to low carbapenem minimum inhibitory concentrations (MICs), was only recently reported in the region. This study aimed to address the knowledge gap regarding the prevalence and characteristics of OXA-244-producing E. coli in a tertiary care hospital in Jerusalem, investigating its proportion among OXA-48-like producers, its transmission routes, genetic diversity, and the genetic context of the resistance gene.
Methods
The researchers employed a multi-pronged approach:
- Screening and Identification: Rectal swabs from patients at Hadassah-Hebrew University Medical Centre were screened for CPEs using selective chromogenic media. Suspected isolates were identified using MALDI-TOF MS and confirmed for carbapenemase genes via multiplex PCR.
- Whole Genome Sequencing (WGS): A representative sample of 53 OXA-48-like-producing E. coli isolates were subjected to short-read WGS for comprehensive characterization.
- Long-Read Sequencing: A subset of isolates underwent long-read sequencing to elucidate the precise genomic environment of the bla<sub>OXA-244</sub> gene.
- Phylogenetic Analysis: Core genome Multi-Locus Sequence Typing (cgMLST) was used to determine sequence types (STs) and construct phylogenetic trees, identifying genomic clusters indicative of common ancestry. Whole genome SNP phylogeny was also employed for finer-scale analysis.
- Resistome and Genetic Context Analysis: Antimicrobial resistance genes and plasmid content were identified using databases like ResFinder and PlasmidFinder. The genetic context of bla<sub>OXA-244</sub>, specifically its integration within the Tn51098 transposon, was analyzed using specialized tools and reference sequences.
- Epidemiological Investigation: The mode of acquisition (in-hospital, healthcare-associated, community-acquired) was classified based on standardized definitions and patient history.
Datasets
The study utilized isolates collected from patients at Hadassah-Hebrew University Medical Centre in Jerusalem, Israel, between January and December 2024. No new public benchmarks were introduced; rather, the study focused on characterizing a local isolate collection.
Key Insights and Ideas
- OXA-244 Dominance: The most striking finding is the unexpected high prevalence of OXA-244, making up 64.2% of the sequenced OXA-48-like E. coli isolates, significantly shifting the landscape from previous expectations for Israel.
- Unique Chromosomal Integration: Unlike other OXA-48-like carbapenemases that often spread via plasmids, bla<sub>OXA-244</sub> consistently integrates chromosomally, primarily within variants of the Tn51098 transposon. This mechanism likely confers enhanced stability and persistence.
- Polyclonal Circulation: Despite evidence of healthcare-associated transmission, the significant genetic diversity (13 distinct STs) among the OXA-244 isolates suggests ongoing, unrecognized community transmission.
- Community Reservoirs: The findings point to the importance of community reservoirs contributing to OXA-244 dissemination, similar to patterns observed in European settings, necessitating a broader surveillance approach.
- Diagnostic Challenge: The low carbapenem MICs associated with OXA-244 can lead to missed diagnoses during routine phenotypic screening, highlighting the need for molecular subtyping.
Key Results
- Out of 53 sequenced OXA-48-like-producing E. coli, the majority harbored bla<sub>OXA-244</sub> (n=34), followed by bla<sub>OXA-48</sub> (n=11) and bla<sub>OXA-181</sub> (n=8).
- For the OXA-244-producing isolates, 88.2% were classified as healthcare-associated (probable or possible in-hospital), while 11.8% were community-acquired.
- The OXA-244 isolates belonged to 13 distinct STs, with seven genomic clusters identified based on cgMLST (≤10 allele differences).
- Long-read sequencing confirmed that bla<sub>OXA-244</sub> was chromosomally located within variants of the Tn51098 transposon.
- The study identified specific instances of direct transmission within hospital wards, but the overall genetic diversity indicated broader circulation.
Limitations and Future Work
The authors acknowledge several limitations:
- Single Center, Single Year: The study's focus on one hospital over one year limits the generalizability of findings to broader regional epidemiology or different time periods.
- Sampling Bias: Analyzing only 53 out of 171 OXA-48-like-producing E. coli might not fully capture the complete genetic diversity and resistance mechanisms.
- Diagnostic Underestimation: The characteristic low carbapenem MICs of OXA-244 could lead to underestimation of its true prevalence due to limitations in routine phenotypic screening.
Future work should focus on:
- Enhanced Surveillance: Implementing molecular subtyping for OXA-48-like variants in routine surveillance is crucial.
- Community-Focused Strategies: Developing community-focused surveillance and prevention strategies to address the identified community reservoirs.
- Mechanism of Integration: Further investigation into the molecular mechanisms that enable bla<sub>OXA-244</sub> to integrate chromosomally across diverse E. coli lineages is warranted.
- Broader Regional Studies: Large-scale molecular epidemiological studies across the region are needed to determine the true prevalence of OXA-244 circulation and its directionality.
Summary updated